Results 131 to 140 of about 3,268,533 (214)

Studies on Hypoglycemic Agents. I

, 1964
Tutomu Irikura, Seigo Suzue
openalex   +2 more sources

Efficacy and safety of hypoglycemic agents on gestational diabetes mellitus in women: A Bayesian network analysis of randomized controlled trials. [PDF]

Front Public Health, 2022
Wang T, Jing Y, Guo H, Xu J, Wang M, Huang L, Chen H, Cui W, Song L, Liu X, Sun B, Wang N.   +11 more
europepmc   +1 more source

Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83). [PDF]

Diabetes Metab J, 2022
Oh TJ.
europepmc   +2 more sources

Studies on Hypoglycemic Agents. III

, 1964
Seigo Suzue
openalex   +2 more sources

Prevalence of Diabetic Retinopathy and Use of Common Oral Hypoglycemic Agents Increase the Risk of Diabetic Nephropathy-A Cross-Sectional Study in Patients with Type 2 Diabetes. [PDF]

Int J Environ Res Public Health, 2023
Luo WM, Su JY, Xu T, Fang ZZ.
europepmc   +1 more source

Adherence to Hypoglycemic Agents in Type 2 Diabetes Mellitus: A Cross-Sectional Study. [PDF]

Cureus, 2022
Khayyat YA, Alshamrani RM, Bintalib DM, Alzahrani NA, Alqutub S.   +4 more
europepmc   +1 more source

Experimental pharmacological approaches to reverse impaired awareness of hypoglycemia—a review

Frontiers in Pharmacology
The colossal global burden of diabetes management is compounded by the serious complication of hypoglycemia. Protective physiologic hormonal and neurogenic counterregulatory responses to hypoglycemia are essential to preserve glucose homeostasis and ...
Hiba Z. Hashmi, Ameer Khowaja, Amir Moheet   +2 more
doaj   +1 more source

Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition. [PDF]

Acta Pharm Sin B, 2023
Xie Y, Zhou Q, He Q, Wang X, Wang J.
europepmc   +1 more source

Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 899 hypertensive patients on oral hypoglycemic agents - subgroup analysis of a 12-week, open-label, aceonS Community Trial (ACT) [PDF]

, 2002
J. N. Cohn
openalex   +1 more source

Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis. [PDF]

Diab Vasc Dis Res, 2022
Oh S, Purja S, Shin H, Kim M, Kim E.
europepmc   +1 more source